Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,148.42
(
0.00%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 69
Posts 4516
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: DewDiligence post# 161558

Thursday, 05/23/2013 1:34:06 PM

Thursday, May 23, 2013 1:34:06 PM

Post# of 257580
Hey, I didn't check twitter, but your tweet is at the bottom of the article. What a load of misleading statements and graphs from JNJ. Xtandi hasn't approved in chemo naive CRPC yet, Zytiga has lost market share in chemo treated since Xtandi's approval, but they stated Zytiga increased market share overall since Zytiga's approval in chemo naive.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today